Pharmaceuticals : Shots - Health News Pharmaceuticals

AstraZeneca's Nexium was the top drug in Medicare Part D's spending on prescription medicines. Daniel Acker/Bloomberg via Getty Images hide caption

toggle caption
Daniel Acker/Bloomberg via Getty Images

Kathy Liu and her son Joey Xu talk to friends back home in Gainesville, Fla., from his hospital room in Cincinnati. Amanda Aronczyk/WNYC hide caption

toggle caption
Amanda Aronczyk/WNYC

Son's Rare Cancer Leads Family On Quest For Cure

  • Download
  • <iframe src="https://www.npr.org/player/embed/383789122/385000773" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Dr. Margaret Hamburg will have served almost six years as FDA commissioner by the time she leaves, far longer than the recent tenure for chiefs of the agency. J. David Ake/AP hide caption

toggle caption
J. David Ake/AP

FDA Commissioner Hamburg Grappled With Global Challenges

  • Download
  • <iframe src="https://www.npr.org/player/embed/384100663/384119730" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Scientists reprogrammed the common bacterium E. coli so it requires a synthetic amino acid to live. BSIP/UIG via Getty Images hide caption

toggle caption
BSIP/UIG via Getty Images

Scientists Give Genetically Modified Organisms A Safety Switch

  • Download
  • <iframe src="https://www.npr.org/player/embed/378820888/378943507" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Arizona Department of Corrections inmate Joseph Wood was executed by lethal injection in July. It took 15 doses and nearly two hours for him to die. AP hide caption

toggle caption
AP

Botched Lethal Injection Executions Reignite Death Penalty Debate

  • Download
  • <iframe src="https://www.npr.org/player/embed/375399560/375434507" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Belviq, a weight-loss drug from Arena Pharmaceuticals, was approved by the Food and Drug Administration in 2012. With the agency's approval of Saxenda in December, there are four new weight-loss pills available. Arena Pharmaceuticals Inc/Reuters/Landov hide caption

toggle caption
Arena Pharmaceuticals Inc/Reuters/Landov

The hepatitis C medication Sovaldi, from Gilead Sciences, costs $1,000 per pill. It's just one of the new medications introduced in the past year that can cure the disease within weeks or months. Courtesy of Gilead Sciences via AP hide caption

toggle caption
Courtesy of Gilead Sciences via AP

Costly Hepatitis C Drugs Threaten To Bust Prison Budgets

  • Download
  • <iframe src="https://www.npr.org/player/embed/372721256/372837243" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Katie Clapp shares a laugh with her son Andy Tranfaglia, 25, at their home in West Newbury, Mass. Andy has a rare genetic condition called fragile X syndrome. Ellen Webber for NPR hide caption

toggle caption
Ellen Webber for NPR

A Family's Long Search For Fragile X Drug Finds Frustration, Hope

  • Download
  • <iframe src="https://www.npr.org/player/embed/371502800/372409645" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Icon Genetics' Dr. Frank Thieme selects samples of Nicotiana benthamiana, a relative of tobacco, growing in a company greenhouse in Halle, Germany. The company uses the plants to produce antibodies that could be helpful for increasing supplies of ZMapp. Sean Gallup/Getty Images hide caption

toggle caption
Sean Gallup/Getty Images

Answering Your Questions About Ebola Treatments And Vaccines

  • Download
  • <iframe src="https://www.npr.org/player/embed/355184997/355188002" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript